Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder

NCT00601367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Sexual Dysfunctions, Psychological

Interventions

DRUG: flibanserin flexible dose

Sponsor

Sprout Pharmaceuticals, Inc